Akari Therapeutics, Plc (AKTX)
NASDAQ: AKTX · Real-Time Price · USD
15.07
-0.77 (-4.86%)
At close: Jun 5, 2026, 4:00 PM EDT
15.50
+0.43 (2.85%)
After-hours: Jun 5, 2026, 7:36 PM EDT

Akari Therapeutics, Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
2.775.22.63.8513.259.36
Cash & Short-Term Investments
2.775.22.63.8513.259.36
Cash Growth
7.20%100.19%-32.41%-70.98%41.54%-33.40%
Prepaid Expenses
0.730.190.090.30.472.17
Restricted Cash
0.060.060.06---
Other Current Assets
0.030.010.20.20.10.09
Total Current Assets
3.595.462.954.3413.8211.63
Goodwill
-8.438.43---
Other Intangible Assets
30.33439.180.010.020.02
Total Assets
33.8947.8950.564.3613.8311.65
Accounts Payable
8.648.7712.411.670.951.79
Accrued Expenses
3.332.343.141.573.153.18
Short-Term Debt
0.730.753.26---
Other Current Liabilities
0.710.491.111.357.951.12
Total Current Liabilities
13.4212.3519.914.5812.046.09
Long-Term Deferred Tax Liabilities
6.096.958.04---
Other Long-Term Liabilities
-0.260.38---
Total Liabilities
19.5119.5628.334.5812.046.09
Common Stock
--5.321.320.750.48
Additional Paid-In Capital
234.81234.32212.71174.75167.08153.13
Retained Earnings
-279.01-264.55-247.25-227.46-217.45-199.71
Comprehensive Income & Other
58.5758.5651.4651.1551.4251.65
Shareholders' Equity
14.3828.3322.23-0.231.795.55
Total Liabilities & Equity
33.8947.8950.564.3613.8311.65
Total Debt
0.730.753.26---
Net Cash (Debt)
2.044.45-0.663.8513.259.36
Net Cash Growth
176.63%---70.98%41.54%-33.40%
Net Cash Per Share
1.955.29-2.2131.42169.78174.48
Filing Date Shares Outstanding
1.141.140.720.20.130.07
Total Common Shares Outstanding
1.141.130.660.170.090.06
Working Capital
-9.83-6.89-16.96-0.241.775.53
Book Value Per Share
12.5625.0333.44-1.3819.2593.36
Tangible Book Value
-15.92-14.1-25.38-0.241.775.53
Tangible Book Value Per Share
-13.91-12.46-38.18-1.4719.0692.97
Machinery
-----0.16
SEC Filings: 10-K · 10-Q